These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 16549967

  • 21. Impact on weight and height with the use of HAART in HIV-infected children.
    Guillén S, Ramos JT, Resino R, Bellón JM, Muñoz MA.
    Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
    [Abstract] [Full Text] [Related]

  • 22. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART.
    Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Fantoni M, Sampaolesi A, Noto P, Ippolito G, Wu AW.
    Int J STD AIDS; 2004 Apr; 15(4):254-9. PubMed ID: 15075020
    [Abstract] [Full Text] [Related]

  • 23. Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study.
    Gathe JC, Wood R, Sanne I, DeJesus E, Schürmann D, Gladysz A, Garris C, Givens N, Elston R, Yeo J.
    Clin Ther; 2006 May; 28(5):745-54. PubMed ID: 16861096
    [Abstract] [Full Text] [Related]

  • 24. High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection.
    Sabundayo BP, McArthur JH, Langan SJ, Gallant JE, Margolick JB.
    Pharmacotherapy; 2006 May; 26(5):674-81. PubMed ID: 16637796
    [Abstract] [Full Text] [Related]

  • 25. Social support and quality of life over time among adults living with HIV in the HAART era.
    Burgoyne R, Renwick R.
    Soc Sci Med; 2004 Apr; 58(7):1353-66. PubMed ID: 14759681
    [Abstract] [Full Text] [Related]

  • 26. Predictors of short-term success of antiretroviral therapy in HIV infection.
    Oette M, Kroidl A, Göbels K, Stabbert A, Menge M, Sagir A, Kuschak D, O'hanley T, Bode JG, Häussinger D.
    J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
    [Abstract] [Full Text] [Related]

  • 27. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
    Collazos J, Asensi V, Cartón JA.
    AIDS; 2007 Apr 23; 21(7):835-43. PubMed ID: 17415038
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SL.
    J Ment Health Policy Econ; 2009 Mar 23; 12(1):33-46. PubMed ID: 19346565
    [Abstract] [Full Text] [Related]

  • 33. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 23; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 34. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.
    HIV Med; 2007 Mar 23; 8(2):75-9. PubMed ID: 17352762
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Evolution of psychosocial factors in a cohort of HIV-infected patients adherent to therapy].
    Delmas P, Coté J, Delpierre C, Sylvain H, Lauwers-Cances V, Delon S.
    Rech Soins Infirm; 2007 Mar 23; (88):38-50. PubMed ID: 17474570
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus.
    Delate T, Coons SJ.
    Clin Infect Dis; 2001 Feb 01; 32(3):E47-52. PubMed ID: 11170970
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.